|1||NCT02701205||Recruiting||Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis||
||216||All||18 Years to 65 Years (Adult)||NCT02701205||QRSTPP||January 2015||January 2017||December 2017||March 8, 2016||March 8, 2016||
|2||NCT00940862||Completed||Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis||
||Other / Industry||
||30||All||18 Years to 80 Years (Adult, Senior)||NCT00940862||Inno-6009||July 2009||June 2011||August 2011||July 16, 2009||October 28, 2011||
† Study has passed its completion date and status has not been verified in more than two years.